Psychomotor stimulants

Psychomotor stimulants

BMB2

BMB2

Seizures: Pathology review
Seizures: Clinical
Febrile seizure
Seizures and epilepsy
Early infantile epileptic encephalopathy (NORD)
Nonbenzodiazepine anticonvulsants
Migraine medications
Migraine
Neuron action potential
Resting membrane potential
Concussion and traumatic brain injury
Sleep
Sleep disorders: Clinical
Anticonvulsants and anxiolytics: Barbiturates
Anticonvulsants and anxiolytics: Benzodiazepines
Essential tremor
Malingering, factitious disorders and somatoform disorders: Pathology review
Somatic symptom disorders: Clinical
Somatic symptom disorder
Dissociative disorders
Dissociative disorders: Clinical
Amnesia, dissociative disorders and delirium: Pathology review
Narcolepsy (NORD)
Psychomotor stimulants
Trigeminal neuralgia
Muscle weakness: Clinical
Myalgias and myositis: Pathology review
Fibromyalgia
Diabetic nephropathy
Tricyclic antidepressants
Atypical antidepressants
Medications for neurodegenerative diseases
Toxidromes: Clinical
Body focused repetitive disorders
Headaches: Clinical
Demyelinating disorders: Pathology review
Serotonin and norepinephrine reuptake inhibitors
Erb-Duchenne palsy
Klumpke paralysis
Lead poisoning
Hemolytic-uremic syndrome
Vitamin B12 deficiency
Monoclonal gammopathy of undetermined significance
Charcot-Marie-Tooth disease
Inflammatory myopathies: Clinical
Guillain-Barre syndrome
Amyotrophic lateral sclerosis
Spinal muscular atrophy
Muscular dystrophy
Spinal cord reflexes
Myotonic dystrophy
Memory palaces
Herpes simplex virus
Neuromuscular junction and motor unit
Slow twitch and fast twitch muscle fibers
Muscle contraction
Development of the muscular system
Development of the axial skeleton
Patellar tendon rupture
Achilles tendon rupture
Lower back pain: Clinical
Carpal tunnel syndrome
Radial head subluxation (Nursemaid elbow)
Bell palsy
Headaches: Pathology review
Cluster headache
Tension headache
Epidural hematoma
Traumatic brain injury: Clinical
Intracerebral hemorrhage
Subarachnoid hemorrhage
Subdural hematoma
Traumatic brain injury: Pathology review
Idiopathic intracranial hypertension
Vasculitis
Vasculitis: Clinical
Dementia with Lewy bodies
Spinocerebellar ataxia (NORD)
Amyloidosis
Vascular dementia
Dementia and delirium: Clinical
Frontotemporal dementia
Dementia: Pathology review
Hypokinetic movement disorders: Clinical
Alzheimer disease
Movement disorders: Pathology review
Delirium
Parkinson disease
Hyperkinetic movement disorders: Clinical
Back pain: Pathology review
Stroke: Clinical
Compartment syndrome
Macrocytic anemia: Pathology review
Hypokalemia: Clinical
Hyperkalemia: Clinical
Hypothesis testing: One-tailed and two-tailed tests
Paired t-test
One-way ANOVA
Two-way ANOVA
Type I and type II errors
Two-sample t-test
Correlation
Repeated measures ANOVA
Meningitis, encephalitis and brain abscesses: Clinical
Neonatal meningitis
Central nervous system infections: Pathology review
Neisseria meningitidis
Streptococcus pneumoniae
Listeria monocytogenes
Brain abscess
Clostridium tetani (Tetanus)
Clostridium botulinum (Botulism)
Encephalitis
Eastern and Western equine encephalitis virus
West Nile virus
Zika virus
Rabies virus
Poliovirus
JC virus (Progressive multifocal leukoencephalopathy)
Knowledge Shot: What is acute flaccid myelitis, the polio-like paralyzing disease
Meningitis
Cryptococcus neoformans
Aspergillus fumigatus
Candida
Mucormycosis
Coccidioidomycosis and paracoccidioidomycosis
Blastomycosis
Histoplasmosis
Chi-squared test
Naegleria fowleri (Primary amebic meningoencephalitis)
Angiostrongylus (Eosinophilic meningitis)
Varicella zoster virus
Mycobacterium tuberculosis (Tuberculosis)
Normal pressure hydrocephalus
Prions (Spongiform encephalopathy)
Measles virus
Central nervous system infections: Pathology review
Meningitis, encephalitis and brain abscesses: Clinical
Adult brain tumors
Pediatric brain tumors: Pathology review
Adult brain tumors: Pathology review
Pediatric brain tumors
Brain tumors: Clinical
Multiple sclerosis
Tourette syndrome
Ataxia-telangiectasia
Huntington disease
Opsoclonus myoclonus syndrome (NORD)
Primary ciliary dyskinesia
Brain herniation
Spinal disc herniation
Multiple myeloma

Transcript

Watch video only

Psychomotor stimulants are drugs that stimulate the central nervous system to increase motor activity and to produce euphoria, excitement, and a feeling of having lots of energy.

Unfortunately, some drugs of abuse, like methamphetamine or cocaine, belong to this class of substances.

However, there are a few medications in this class that do have clinical applications so let’s go over those.

To understand how psychomotor stimulants work, let’s zoom in on one of the synapses of the brain.

Normally electrical signals, or action potentials, travel down the axon to the axon terminal, where they trigger the release of chemical messengers, called neurotransmitters, from synaptic vesicles into the synapse.

The neurotransmitters travel across the synapse and bind to receptors on the postsynaptic neuron, where they give the cell a message.

After the neurotransmitters have done their job, they unbind from the receptors, and can: diffuse away, get degraded by enzymes, or get picked up by proteins and returned to their original release site in a process called reuptake.

Psychomotor stimulants, in general, increase the release of certain neurotransmitters, but their biggest effect is blocking reuptake receptors on presynaptic axon terminals.

Both actions keep neurotransmitters - like dopamine, norepinephrine, and serotonin - in the synapse longer, and increases their effects.

For example, increased concentrations of dopamine in the brain’s reward pathway, which includes the nucleus accumbens, ventral tegmentum, and prefrontal cortex, produce intense feelings of euphoria, pleasure, and the emotional “high” associated with psychomotor stimulants.

The physical “high” or feeling of hyper-stimulation is caused by increased norepinephrine concentrations throughout the brain, which produces a variety of effects throughout the body like increased energy, constricted blood vessels, dilated pupils, increased body temperature, increased heart rate, and increased blood pressure.

And finally, higher levels of serotonin are associated with greater confidence and happiness, and decreased anxiety.

Okay, for psychomotor stimulants with medical applications, let’s start with the popular methylxanthines.

We are all familiar with this class of medication since it includes caffeine and theophylline found in coffee and tea respectively.

Now both these substances cause a stimulatory effect by blocking receptors for adenosine, a chemical that has numerous effects in the body like decreasing heart rate, decreasing neuronal activity - triggering sleepiness, and dilating blood vessels.

Now, migraines and other headaches can be caused by increased adenosine levels in the brain, so caffeine is often combined with an NSAID or acetaminophen to treat them.

Theophylline, on the other hand, is used to treat respiratory disorders like COPD and asthma.

It works by inhibiting the enzyme phosphodiesterase, or PDE, in the smooth muscles in the respiratory tract.

Normally phosphodiesterase converts cAMP into an inactive form called 5-AMP.

By inhibiting this enzyme, we increase the level of cAMP within the cell, and trigger smooth muscle relaxation and bronchodilation.

An overdose of methylxanthines can cause anxiety, nausea, arrhythmia, and seizures, so watch your coffee intake!

Another medication that can help you stay awake is Modafinil.

It’s mainly used to treat narcolepsy, a condition where the person can fall asleep at any moment of the day and has episodes of paralysis out of the blue - not cool, right?

Well, modafinil inhibits dopamine reuptake and increases the release of glutamate and histamine in the brain, all of which increases arousal.

Modafinil is sometimes used as a “cognitive enhancer” off-label, but there’s no research to support this claim.

Okay, let’s move on to the next group of medication like amphetamines and methylphenidate which work by blocking the reuptake of dopamine and norepinephrine at the presynaptic neuron.

It’s the preferred treatment for attention deficit/hyperactivity disorder, or ADHD for short, because it helps improve focus and decreases the impulsivity common in people with this disorder.

It also doesn’t have major side effects, making it the preferred medication.

Finally, we have cocaine, sometimes called coke, which is a powerful psychomotor stimulant that has been used for over a thousand years.

Key Takeaways

Psychomotor stimulants are medications that stimulate the central nervous system to increase alertness, attention, and energy levels. Some psychomotor stimulants, like modafinil, methylphenidate, and cocaine work by increasing the amount of dopamine, norepinephrine, and serotonin in the synapse by preventing their reuptake. Others, like the methylxanthines, block the action of adenosine, which normally decreases neuronal activity and causes drowsiness. Common side effects include agitation; insomnia, tachycardia, hypertension, tics, and anorexia.

Sources

  1. "Katzung & Trevor's Pharmacology Examination and Board Review,12th Edition" McGraw-Hill Education / Medical (2018)
  2. "Rang and Dale's Pharmacology" Elsevier (2019)
  3. "Goodman and Gilman's The Pharmacological Basis of Therapeutics, 13th Edition" McGraw-Hill Education / Medical (2017)
  4. "Behavioral effects of caffeine and other methylxanthines on children" Exp Clin Psychopharmacol (1998)
  5. " Caffeine and theophylline counteract diazepam effects in man" Med Biol (1983)
  6. "Amphetamine, past and present--a pharmacological and clinical perspective" J Psychopharmacol (Oxford) (2013)
  7. "Autonomic actions of cocaine" Can J Physiol Pharmacol (1989)
  8. "Modafinil for cognitive neuroenhancement in healthy non-sleep-deprived subjects: A systematic review" Eur Neuropsychopharmacol (2015)